🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the effect of 6 g/day ac...
Status
Completed
Location
University of California, Irvine
Start Date
2015-05-20
Trial ID
NCT02377921
Treatments Being Tested
GNE myopathy or hereditary inclusion body myopathy (HIBM) is a severe progr...
Status
Completed
Location
UCLA Medical Center
Start Date
2012-05
Trial ID
NCT01517880
Treatments Being Tested
The primary objective of this Phase 2 study is to evaluate the safety of op...
Status
Terminated
Location
University of California, Irvine
Start Date
2016-04-29
Trial ID
NCT02731690
Treatments Being Tested
Sialic Acid-Extended Release (SA-ER, aceneuramic acid, UX001) is an extende...
Status
Completed
Location
Multiple Locations
Start Date
2016-09
Trial ID
NCT02845609
Treatments Being Tested
The safety objectives of the study are to: evaluate additional long-term sa...
Status
Completed
Location
UCLA Medical Center
Start Date
2013-06-04
Trial ID
NCT01830972
Treatments Being Tested
Hereditary Inclusion Body Myopathy (HIBM) is a severe progressive metabolic...
Status
Completed
Location
West Coast Clinical Trials
Start Date
2011-07
Trial ID
NCT01359319
The objective of this study is to evaluate the long-term safety and efficac...
Status
Terminated
Location
UCLA
Start Date
2016-05-02
Trial ID
NCT02736188
Treatments Being Tested